Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2026-01-04 @ 5:10 PM
Study NCT ID:
NCT04914403
Status:
UNKNOWN
Last Update Posted:
2023-12-04
First Post:
2021-05-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mesenchymal Stem Cells for The Treatment of Frailty Syndrome
Sponsor:
Meridigen Biotech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-31
First Submit QC Date:
None
Study First Post Date:
2021-06-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-01
Last Update Post Date:
2023-12-04
Last Update Post Date Type:
ACTUAL